What is Spinal Kinetics?
Spinal Kinetics is the developer of Computerized Radiographic Mensuration Analysis (CRMA), a sophisticated diagnostic technology engineered to identify spinal ligament injuries and intersegmental instability that traditional MRI scans often overlook. By leveraging a network of board-certified medical radiologists, the company provides clinicians with precise, unbiased data regarding spinal motion abnormalities. This service addresses a critical gap in the management of chronic pain, which affects approximately 100 million adults, by offering a standardized, high-accuracy assessment tool that integrates seamlessly into existing chiropractic and orthopedic workflows. The company's business model focuses on high-volume diagnostic support, positioning it as an essential partner for practitioners addressing the high incidence of spinal trauma resulting from automotive, workplace, and domestic accidents.
How much funding has Spinal Kinetics raised?
Spinal Kinetics has raised a total of $40.4M across 3 funding rounds:
Unspecified
$5.3M
Private Equity
$33.8M
Debt
$1.3M
Unspecified (2009): $5.3M, investors not publicly disclosed
Private Equity (2014): $33.8M led by HLM Venture Partners, Lumira Capital, De Novo Ventures, SV Life Sciences, and BA Venture Partners
Debt (2016): $1.3M, investors not publicly disclosed
Key Investors in Spinal Kinetics
HLM Venture Partners
A specialized healthcare investment firm that partners with innovative founders to build enduring companies in healthcare technology and services.
SV Life Sciences
A specialist investment firm backing innovative health care and life science companies, providing capital and sector expertise from early growth through scale.
De Novo Ventures
A venture capital firm focused on early-stage investments in the medical device and biotechnology sectors, supporting companies with high clinical impact.
What's next for Spinal Kinetics?
With the recent influx of capital, Spinal Kinetics is well-positioned to scale its diagnostic infrastructure and enhance its market penetration. The strategic focus will likely center on broadening the adoption of CRMA technology among primary care and specialized pain management providers. By optimizing its 24-48 hour turnaround time for diagnostic reporting, the company aims to set a new standard for clinical efficiency in spinal health. Future growth initiatives are expected to leverage this recent financing to refine its proprietary algorithms and potentially expand its diagnostic suite, ensuring that the firm remains at the forefront of non-invasive spinal injury assessment and chronic pain diagnostics.
See full Spinal Kinetics company page
